Cand.scient. Ana Slipicevic - from Vivi Ann Flørenes's group at the Division of Pathology - will give her trial lecture on the subject "Dysregulation of apoptosis in cancer. An update" on Tuesday May 4th at 15.15.
She will defend her PhD thesis - entitled "Studies of the PI3K/Akt and MAPK/ERK1/2 signaling pathways: identification of novel downstream targets involved in development and progression of melanoma" at 10.15 on Wednesday May 5th.
Venue for both events: Auditorium (BU1), Radiumhospitalet, Montebello, Oslo
From major journals, first or last author from the Institute for Cancer Research
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler
Cancers (Basel), 13 (17)
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
Nat Commun, 12 (1), 5307
Towards evidence-based personalised precision medicine for Lynch syndrome
Lancet Oncol, 22 (9), e383